SAR441566 matching Placebo
Sponsors
Sanofi
Conditions
Colitis UlcerativeCrohn's Disease
Phase 2
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
Active, not recruitingNCT06637631
Start: 2024-12-10End: 2026-10-14Target: 260Updated: 2026-09-11
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Active, not recruitingNCT06867094
Start: 2025-03-28End: 2026-10-14Target: 204Updated: 2026-09-11